HomeCompareZEOOF vs NOBL

ZEOOF vs NOBL: Dividend Comparison 2026

ZEOOF yields 5.10% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZEOOF wins by $6876.18M in total portfolio value
10 years
ZEOOF
ZEOOF
● Live price
5.10%
Share price
$9.35
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6876.20M
Annual income
$6,626,566,862.72
Full ZEOOF calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — ZEOOF vs NOBL

📍 ZEOOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZEOOFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZEOOF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZEOOF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZEOOF
Annual income on $10K today (after 15% tax)
$433.45/yr
After 10yr DRIP, annual income (after tax)
$5,632,581,833.31/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, ZEOOF beats the other by $5,632,581,621.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZEOOF + NOBL for your $10,000?

ZEOOF: 50%NOBL: 50%
100% NOBL50/50100% ZEOOF
Portfolio after 10yr
$3438.11M
Annual income
$3,313,283,556.25/yr
Blended yield
96.37%
📊

Analyst Conviction Gap

Where Wall Street is split right now

ZEOOF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
3.0
Piotroski
4/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZEOOF buys
0
NOBL buys
0
No recent congressional trades found for ZEOOF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZEOOFNOBL
Forward yield5.10%2.17%
Annual dividend / share$0.48$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$6876.20M$22.9K
Annual income after 10y$6,626,566,862.72$249.78
Total dividends collected$6858.71M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ZEOOF vs NOBL ($10,000, DRIP)

YearZEOOF PortfolioZEOOF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,720$1,019.89$10,917$217.08+$803.00ZEOOF
2$14,774$2,234.21$11,903$221.48+$2.9KZEOOF
3$21,073$5,264.53$12,962$225.68+$8.1KZEOOF
4$36,584$14,035.40$14,099$229.68+$22.5KZEOOF
5$84,688$45,543.66$15,319$233.49+$69.4KZEOOF
6$287,681$197,064.83$16,628$237.10+$271.1KZEOOF
7$1,559,068$1,251,248.54$18,033$240.53+$1.54MZEOOF
8$14,343,060$12,674,857.55$19,539$243.78+$14.32MZEOOF
9$233,301,747$217,954,673.10$21,154$246.86+$233.28MZEOOF
10$6,876,199,732$6,626,566,862.72$22,884$249.78+$6876.18MZEOOF

ZEOOF vs NOBL: Complete Analysis 2026

ZEOOFStock

Zeon Corporation engages in the elastomers, specialty materials, and other businesses. The company offers synthetic rubbers, such as general-purpose rubbers for use in automobile tire applications; and various specialty rubbers, including NBR and hydrogenated NBR. It also provides synthetic latex comprising styrene-butadiene copolymer latex, polybutadiene, acrylonitrile butadiene copolymer latex, acrylate latex, and soap-free latex for use in processed paper, fiber treatment agents, adhesives, paints, and rubber gloves; and materials for adhesive tapes and hot melt adhesives, binder for traffic paints, and concrete admixtures. In addition, the company offers specialty chemicals, such as synthetic aroma chemicals for flavors and fragrances; cyclopentene, cyclopentanone, and other derivatives for chemical synthesis; intermediates for pharmaceuticals and agrochemicals; and solvents and cleaning agents. Further, it provides electronic materials, rechargeable battery materials, and toners for the production of semiconductors, etching gas, and materials used in rechargeable battery production; and specialty plastics that include cyclo olefin polymers and fine processed products with cyclo olefin polymer for use in optical lenses, medical devices, and various general-purpose engineering plastics. Additionally, the company develops, manufactures, and sells cardiovascular and gastrointestinal medical equipment, as well as nutritional products; and licenses butadiene recovery and butene purification process technologies in approximately 23 countries worldwide. It also offers PENTAM, a resource- and energy-saving molded product. The company was founded in 1950 and is headquartered in Tokyo, Japan.

Full ZEOOF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this ZEOOF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZEOOF vs SCHDZEOOF vs JEPIZEOOF vs OZEOOF vs KOZEOOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.